A NEW drug for people with epilepsy was launched this week by a company based in Hatfield.
Japanese drug firm Eisai, which has its UK head office in Mosquito Way, has announced the launch of Zebinix, a novel, once-daily drug for adults who suffer from partial-onset seizures – the most common type of epilepsy.
Patients using Zebinix have reported better seizure control, health-related quality of life and a reduction in depressive feelings, which can be a symptom of poorly controlled epilepsy.
Eisai UK managing director Nick Burgin said: “The effective treatment of patients with partial-onset seizures remains a major challenge for clinicians as well as patients and their families.
“We are delighted to be bringing patients such a promising new treatment.”
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here